Table 2.
Year/Author/Country | Purpose of Study | Sample | Types of Disease | Types of Outcomes and Measurements | Main Results |
---|---|---|---|---|---|
2009 Kearney et al. United Kingdom | To evaluate the impact of a mobile phone-based remote monitoring, advanced symptom management system (ASyMS©) on the incidence, severity and distress of six chemotherapy-related symptoms in patients with lung, breast, or colorectal cancer. | n = 112 (56 in each intervention or control group) patients from 7 clinical sites throughout the UK. Inclusion criteria: commencing a new course of chemotherapy treatment, receiving outpatient chemotherapy, age ≥ 18, written informed consent given, able to read and write English, and deemed by members of the clinical team as being physically and psychologically fit to participate in the study. | Chemotherapy related toxicity in patients with lung, breast, or colorectal cancer | • Severity and distress of the six symptoms including vomiting, nausea, diarrhea, hand-foot syndrome, sore mouth/throat, and fatigue. • Incidence – (did symptom occur? Y/N), Severity and distress (scores 0–3) of the six individual symptoms. • ASyMS has integrated the Common Toxicity Criteria Adverse Events (CTCAE) grading system and the Chemotherapy Symptom Assessment Scale. • Paper version of the electronic symptom questionnaire was administrated at baseline, chemotherapy cycles 2, 3, 4, and 5 in both groups. |
• Two of the six symptoms measured (fatigue and hand-foot syndrome) showed statistical significance between the control and intervention groups (respectively, p = 0.040, p = 0.031). • Patients reported improved communication with health professionals, improvements in the management of their symptoms, and feeling reassured their symptoms were being monitored while at home when using ASyMS. |
2013 Kristjánsdóttir et al. Norway | To study the long term effects of a 4-week smartphone intervention with diaries and therapist feedback following an inpatient chronic pain rehabilitation program (11-month follow up of 2013 Kristjánsdóttir et al. study) | n = 135 (intervention group: 69/control group: 66) Inclusion criteria: female, age ≥ 18, participating in the inpatient multidimensional rehabilitation programfor chronic pain, having chronic widespread pain > 6 months (with or without diagnosis of fibromyalgia), not participating in another research project at the rehab center, being able to use a smartphone, and not being diagnosed with a profound psychiatric disorder. | Chronic widespread pain or Fibromyalgia | • Catastrophizing [Pain catastrophizing scale (PCS)] • Acceptance [Chronic pain acceptance questionnaire (CPAQ)] • Emotional distress [modified General Health Questionnaire (GHQ)] • Importance and success in living according to one’s own values in 6 domains (family, intimate relationships, friendship, work, health, and personal growth) [Chronic Pain Values Inventory (CPVI)] • Pain, fatigue, sleep disturbance [Visual analog scales (VAS)] • Impact of Fibromyalgia on functioning and symptom levels the past week [Fibromyalgia Impact Questionnaire (FIQ)] • Functioning [Short-Form Health Survey (SF-8)] • Use of noninteractive website [self-report at T3 (4 weeks after discharge)] • Feasibility of the smartphone intervention (single question for post-intervention) |
Short-term follow-up results: • Intervention group reported less catastrophizing (p < 0.001). • Results from the per-protocol analysis indicate intervention with diaries and written personalized feedback reduced catastrophizing and increased acceptance and effects persisted 5 months after the intervention. • Increased improvement in values-based living in the intervention group • Control group showed an increased level of fatigue and a tendency toward an increase in sleep disturbance at the 5-month follow-up. Long-term 11-month follow-up results: • The between-group differences on catastrophizing, acceptance, functioning, and symptom level were no longer evident (p > 0.10). • More improvement in catastrophizing scores during the follow-up period (T2-T5) in the intervention group (p = 0.045) • Positive effect on acceptance was found within the intervention group (p < 0.001). • Small to large negative effects were found within the control group on functioning and symptom levels, emotional distress, and fatigue (p = 0.05). • Reduction in disease impact (measured by FIQ) found for intervention group (p = 0.03). • Long-term results are ambiguous. |
2013 Garcia-Palacios et al. Spain | To compare compliance with paper diary vs. smartphone diary, aggregated ecological momentary assessment (EMA) data vs. retrospective data, and assess acceptability of EMA procedures. | n = 40 (intervention group:20/control group:20) Inclusion criteria: met criteria for FMS, defined by the American College of Rheumatology and were diagnosed by a rheumatologist. | Fibromyalgia syndrome (FMS) | • EMA pain and fatigue (0–10 Numerical Rating Scales) • Mood (face-based pictorial 7-point scale) • Weekly retrospective rating of pain and fatigue [Brief Pain Inventory (BPI) and Brief Fatigue Inventory (BFI)] • Acceptability and preferences (self-report) |
• Smartphone condition (smartphone diary) showed higher levels of compliance than paper condition (paper diary) (p < 0.01). • Retrospective assessment produces overestimation of events (pain and fatigue, p < 0.01). • Smartphone condition preferred and accepted over paper diary, even in participants with low familiarity with technology. |
2014 Vuorinen et al. Finland | To study whether multidisciplinary care with telemonitoring leads to decreased HF-related hospitalization | n = 94 (intervention group: 47/control group: 47) Inclusion criteria: diagnosis of systolic heart failure, age 18–90 years, NYHA (New Work Heart Association) functional class ≥2, left ventricular ejection fraction ≤35%, need for a regular check-up visit, and time from the last visit of less than 6 months. | Heart failure (HF) | • Number of HF-related hospital days (data from hospital electronic health record system) • Clinical effectiveness [death from any cause, heart transplant operation or listing for transplant operation, left ventricular ejection fraction (LVEF,%) measured by echocardiography, plasma concentration of N-terminal of the prohormone brain natriuretic peptide (NT-proBNP, ng/1), creatinine, sodium, and potassium] • Self-care behavior (European Heart Failure Self-Care Behavior Scale) • Use of health care resources (analyzed outpatient visits) |
• No difference found in the number of HF-related hospital days (p = 0.351). • Intervention group used more health care resources. • No statistically significant differences in patients’ clinical health status or self-care behavior. |
2015 Cingi et al. Turkey | To investigate the impact of a mobile patient engagement application on health outcomes and quality of life | n = 2282 interventions (physician on call patient engagement trial, POPET for patients with allergic rhinitis or asthma) POPET-AR (intervention group: 88/control group: 51) POPET-Asthma (intervention group: 60/control group:29) | Allergic rhinitis (AR) and asthma patients | • Health outcomes and quality of life [AR groups: Rhinitis Quality of Life Questionnaire (RQLQ), asthma groups: Asthma Control Test (ACT)] | • POPET-AR group showed better clinical improvement than the control group in terms of overall RQLQ score as well in measures of general problems, activity, symptoms other than nose/eye, and emotion domains (p < 0.05). • More patients in the POPET-Asthma group achieved a well-controlled asthma score compared to the control group (p < 0.05). |
2015 Dicianno et al. United States | To determine feasibility of the interactive mobile health and rehabilitation (iMHere) system and its effects on psychosocial and medical outcomes | n = 23 (intervention group:13/control group:10) Inclusion criteria: age 18–40, primary diagnosis of myelomeningocele with hydrocephalus, ability to use smartphone, and living within 100 miles of testing site to allow for technical support. | Spina bifida (SB) | • Usage (the number of participant responses to reminders, use of secure messaging, or photo uploads) • Physical independence (Craig Handicap Assessment and Reporting Technique Short Form, Physical independence domain) • Self management skill (Adolescent Self-Management and Independence Scale II) • Depressive symptoms (The Beck Depression Inventory-II) • Perception of patient-centered care (Patient Assessment of Chronic Illness Care) • Quality of Life (World Health Organization Quality of Life Brief Instrument) • Number of UTIs (diagnosed UTIs) • Number of wounds (unique skin breakdown episodes that were at least stage II) • Number of emergency department (ED) visits (ED visits for any reason) • Number of ED visits due to UTI or wound • Number of planned and unplanned hospitalizations • Number of hospitalizations due to UTI or wound |
• Smartphone system was found to be feasible and associated with short-term self-reported improvements in self-management skills. |
2015 Hägglund et al. Sweden | To evaluate whether a home intervention system (HIS) using a tablet had an effect on self-care behavior. | n = 82 (intervention group:42/control group:40) Inclusion criteria: hospitalized and diagnosed for HF with reduced ejection fraction (HFrEF) and/or preserved EF (HFpEF), treatment with diuretics, and referred straight to primary care. | Heart failure (HF) | • Disease-specific self-care (European Heart Failure Self-Care Behavior Scale) • Health-related quality of life (HRQoL) (Kansas City Cardiomyopathy Questionnaire) • Adherence (frequency of HIS use) • Knowledge (Dutch Heart Failure Knowledge Scale) • HF-related hospital days (patients’ case books) |
• Intervention group showed improvement in self-care and HRQoL, reduction in HF-related hospital days. |
2015 Martin et al. United States | To investigate whether a fully automated mHealth intervention with tracking and texting components increases physical activity. | n = 48 [unblinded = 32 (smart texts = 16, no texts = 16), blinded = 16] Unblinded participants were randomized to smart texts or no texts in phase II (weeks 4–5). Inclusion criteria: ages 18–69, using a Fitbug compatible smartphone (iPhone≥4S, Galaxy≥S3). | Cardiovascular disease (CVD) | • Mean change in accelerometer-measured daily step count (measured by Fitbug Orb) • Attainment of prescribed 10,000 steps/day goal (measured by Fitbug Orb) • Changes in total daily activity and aerobic time (measured by Fitbug Orb) |
• Intervention with texting component increased physical activity (p < 0.001). |
2015 Piette et al. United States | To compare the effects of systematic feedback to HF patients’ caregivers and HF patients receiving standard mHealth. | n = 372 (intervention group:189/control group: 183) Inclusion criteria: HF diagnosis, ejection fraction < 40%, able to name eligible CarePartner (CP) that is a relative or friend living outside their home. | Heart failure (HF) | • HF-related quality of life (Minnesota Living with Heart Failure Questionnaire) • Patient-CP communication (quantitative telephone surveys) • Medication adherence and self-care (Revised Heart Failure Self-Care Behavior Scale) |
• mHealth + CP (intervention) group showed improvement in medication adherence and caregiver communication. • mHealth + CP may improve qualify of life in patients with greater depressive symptoms and also decrease patients’ risk of shortness of breath and sudden weight gains. |
2016 Cubo et al. Spain | To evaluate the cost-effectiveness of home-based motor monitoring (HBMM) with in-office visits versus in-office visits alone in patients with advanced Parkinson’s disease | n = 40 (intervention group: 20/control group: 20) Inclusion criteria: non-demented outpatients from a tertiary regional movement disorders clinic, Mini-Mental Scale score > 24, and diagnosed with idiopathic, advanced PD. | Parkinson’s disease (PD) | • Motor (Unified Parkinson’s Disease Rating Scale and Hoehn and Yahr staging Scale) and non-motor (Non-Motor Symptoms Questionnaire Scale) symptom severities • Cost-effectiveness (incremental cost-effectiveness ratio) • Direct costs (standardized questionnaire) • Quality of life (EuroQoL) • Neuropsychiatric symptoms (Hospital Anxiety Depression Scale, Scale for Evaluation of Neuropsychiatric Disorders, Parkinson Psychiatric Rating Scale) • Comorbidities (Cumulative Illness Rating scale-Geriatric) |
• HBMM was found to be cost-effective in improvement of functional status, motor severity, and motor complications. |
2016 DeVito Dabbs et al. United States | To compare the efficacy of an mHealth intervention in promoting self-management behaviors and self-care agency, rehospitalization, and mortality at home during the first year after lung transplantation. | n = 201 (intervention group: 99/control group: 102) Inclusion criteria: age > 18, received transplantation at the University of Pittsburgh Medical Center, and could read and speak English. | Lung transplant recipients (LTRs) | • Self-monitoring (percentage of days that LTRs performed self-monitoring) • Adherence to regimen (Health Habits Survey) • Critical health (percentage of critical indicators) • Self-care agency (Perception of Self-Care Agency) • Health outcomes (medical records) |
• The intervention group performed self-monitoring (p < 0.001), adhered to medical regimen. (p = 0.046), and reported abnormal health indicators (p < 0.001) more frequently. Than the usual care group. • Both groups did not differ in re-hospitalization (p = 0.51) or mortality (p = 0.25). |
2016 Ginis et al. Israel and Belgium | To determine the feasibility and effectiveness of the gait training CuPiD-system for people with Parkinson’s disease in the home environment. | n = 40 (intervention group: 22/control group: 18) Inclusion criteria: ability to walk 0 min continuously, score of ≥24 on Montreal Cognitive Assessment, Hoehn and Yahr Stage II to III in ON-state, and on stable PD medication. | Parkinson’s disease (PD) | • Single and dual task gait (gait speed) • Balance (mini-Balance Evaluation Systems Test, Four Square Step Test, Falls Efficacy Scale-International) • Endurance and physical capacity (2 Minute Walk Test, Physical Activity Scale for the Elderly) • Disease severity (Movement Disorders Unified Parkinson’s Disease Rating Scale – motor examination) • Freezing of gait (New FOG Questionnaire, Ziegler protocol) • Cognition (Color Trail Test A & B, sitting & walking verbal fluency) Quality of life (Short Form 36 Health Survey) |
The CuPiD-system was feasible and effective, as the intervention group improved significantly more on balance and maintained quality of life compared to the control group. |